Analysts say this stock could see 20%+ upside over the next year.
Read MoreThe sector these 6 stocks belong to has been smashing the broader market lately.
Read MoreThis sector boasts both value and growth plays, and one trader says the group is “starting to fire on all cylinders.”
Read MoreIf history is any guide, the S&P 500 could soon rocket higher.
Read MoreThese 6 stocks have been surging lately and could continue to head higher. Here’s why.
Read MorePlus, the U.S. and China hit another snag in negotiations, jobless claims jumped to their highest level in 5 months, and activist investors are going after Instructure.
Read MoreTrade Setup Buy Target – $46.00 or better Sell Target – TradersPro Sell Signal ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson’s […]
Read MoreOne of the interesting things about investing is the way the community of investors interacts and shares information. As competitive as the market can be – everybody trying to find their own respective edge, or advantage that an investing system can provide – people are remarkably willing to share information. Why? Because the truth is […]
Read More